Multi-Nutrient Supplement for Radio-Protection
Launched by MCMASTER UNIVERSITY · Mar 1, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a special combination of nutrients, known as antioxidants, can help protect your white blood cells from damage caused by radiation during medical scans like bone scans or CT scans. When you undergo these scans, the radiation can create harmful stress in your body that affects your DNA, the material that carries your genetic information. While a single scan isn’t usually harmful, people who need multiple scans might face more significant risks. The goal of this study is to see if taking these antioxidants before a scan can help reduce or prevent this damage.
To participate in this trial, you need to be between 18 and 76 years old and have a bone scan scheduled at Juravinski Hospital. However, if you have smoked in the past six months, have allergies to any ingredients in the supplement, or have undergone chemotherapy or radiation therapy recently, you won’t be able to take part. If you are currently taking any vitamin or mineral supplements with antioxidants, you might be asked to stop for two weeks before joining the study. Participants will be closely monitored during the trial to assess the effectiveness of the antioxidant combination.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 76 years.
- • Scheduled for bone scan procedure at the Juravinski Hospital.
- Exclusion Criteria:
- • History of smoking within six months prior to study enrollment.
- • Known hypersensitivity reactions to any of the ingredients in the MNSRP.
- • Chemotherapy or radiation therapy within six months prior or one month following study enrollment.
- • Individuals currently taking vitamin or mineral supplements that contain antioxidants will be considered on a case-by-case basis but will be asked to refrain from intake for at least two weeks prior to partaking in this study.
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials